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1339in patients with unilateral, asymptomatic stenoses is tenuous, to say
the very least. Accordingly, the statement in an accompanying
editorial by Mahmud and Reeves (8) that this study “provides
clarity for the management of patients with carotid and coronary
disease” is not supported on the basis of currently available evi-
dence. Moreover, the caveat that surgeons are loath to perform
isolated CABG in this situation and that Shishehbor et al.’s (1)
study represents “real-world practice” cannot be used to justify an
uncritical policy of prophylactic carotid interventions with little or
no supporting evidence.*A. Ross Naylor, MD
*Vascular Research Group
Division of Cardiovascular Sciences
Clinical Sciences Building
Leicester Royal Inﬁrmary
Leicester LE2 7LX
United Kingdom
E-mail: ross.naylor@uhl-tr.nhs.uk
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Always What They Seem
Dr. Naylor, in his commentary on the report by Shishehbor et al.
(1), has brought up an important point regarding the optimal
treatment strategy for patients with asymptomatic unilateral carotid
disease. Since the pivotal trials comparing carotid endarterectomy
with medical therapy almost 2 decades ago (2,3), it has been
accepted that carotid endarterectomy is superior to medical therapy
in lowering the future risk for stroke in patients with asymptomatic
high-grade carotid disease. Whether contemporary medical therapy
with potent antiplatelet, lipid-lowering, and antihypertensive ther-
apy has narrowed the gap between these 2 strategies is unknown.The study by Shishehbor et al. (1) addresses the optimal revas-
cularization strategy before open-heart surgery (OHS), and it was
not designed to address the role of optimal medical therapy before
OHS. The patients included in the study had high-grade carotid
disease and met established indications for carotid revasculariza-
tion. Therefore, the role of medical therapy alone as a long-term
treatment strategy for these patients is irrelevant.
Additionally, Dr. Naylor has quoted us out of context. The
complete statement in our editorial (4) is “This study provides clarity
in the management of patients with carotid and coronary disease
requiring OHS.” The Coronary Artery Bypass Graft Surgery in
Patients With Asymptomatic Carotid Stenosis trial is currently
randomizing patients with asymptomatic severe carotid disease
requiring coronary artery bypass grafting to combined coronary ar-
tery bypass grafting and carotid endarterectomy versus isolated
coronary artery bypass grafting (5). Until the results of this trial are
available, the study by Shishehbor et al. (1) provides a prudent data-
driven strategy for optimal carotid revascularization before OHS.*Ehtisham Mahmud, MD
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Stroke 2012;7:354–60.ReplySometimes, Things Are Not
Always What They SeemWe do share the concerns raised by Dr. Naylor regarding the use of
carotid revascularization for “low-risk” asymptomatic unilateral
carotid disease in the open-heart surgery (OHS) population.
